Literature DB >> 25395116

Anatomic surgical management of chronic low back pain.

Bohdan Chopko1, John C Liu, Mohammad K Khan.   

Abstract

OBJECTIVE: To review spine surgery management strategies for patients with chronic low back pain (CLBP) that has failed to respond to all nonsurgical treatment options.
MATERIALS AND METHODS: Literature review was conducted for spine surgery in the treatment of CLBP without compressive anatomical disease. The main diagnosis identified was degenerated disc disease, and surgical options targeted for the treatment of CLBP were reviewed.
RESULTS: The history of current spine intervention for CLBP was reviewed, including various surgical options. Surgical treatment options for patients with CLBP include lumbar fusion, lumbar disc arthroplasty, and dynamic stabilization. Lumbar fusion remains the most frequent spine surgery performed for CLBP, but questions still exist regarding its efficacy in comparison with conservative care or interventional pain management. Lumbar disc arthroplasty and dynamic stabilization can both be considered only for select patients with CLBP, and their uses are currently limited.
CONCLUSION: Despite the number of spine surgeries that have been performed for CLBP, the surgical outcome still remains questionable. Until a precise identification of the cause of CLBP in any given patient can be precisely determined, surgical solutions will continue to be less than optimal.
© 2014 International Neuromodulation Society.

Entities:  

Keywords:  Chronic low back pain; surgery

Mesh:

Year:  2014        PMID: 25395116     DOI: 10.1111/ner.12169

Source DB:  PubMed          Journal:  Neuromodulation        ISSN: 1094-7159


  2 in total

1.  We Need to Talk about Lumbar Total Disc Replacement.

Authors:  Stephen Beatty
Journal:  Int J Spine Surg       Date:  2018-08-03

2.  Efficacy and safety of Daoyin and massage for lumbar disc herniation: A protocol for overview of systematic reviews.

Authors:  Mingpeng Shi; Xianshuai Zhang; Siyi Wang; Shaojun Li; Changwei Zhao; Zhenhua Li; Jianan Li
Journal:  Medicine (Baltimore)       Date:  2022-02-04       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.